| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Care Providers Of Minnesota is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ICTI (Interactive Clinical Technologies) is a Yardley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The best inpatient drug rehabs Los Angeles options offering evidence-based, personalized addiction treatment. Our alcohol detox centers LA
CCS Assoc is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.